There are 3161 resources available
Q&A and discussion
Session: ESMO-CDDF – Regulatory challenges in clinical cancer drug development
Resources:
Webcast
Invited Discussant 69MO, 70MO and 1171MO
Presenter: Angela George
Session: Mini oral session: Basic science & Translational research
Resources:
Slides
Webcast
Invited Discussant 347MO, 348MO and 349MO
Presenter: Carmen Criscitiello
Session: Mini oral session 2: Breast cancer, metastatic
Resources:
Slides
Webcast
Invited Discussant 1963O, 1960O and LBA84
Presenter: Bogdana Schmidt
Session: Proffered Paper session 2: GU, non-prostate
Resources:
Slides
Webcast
Quality of life
Presenter: Silvia Novello
Session: Improving outcome in long-term survivors with metastatic NSCLC
Resources:
Slides
Webcast
Q&A and discussion
Session: Protein degradation as a novel approach for cancer therapy
Resources:
Webcast
LBA63 - A randomized phase I/II study of second line treatment with liposomal irinotecan and S-1 versus liposomal irinotecan and 5-fluorouracil in patients with metastatic pancreatic cancer following gemcitabine-based chemotherapy
Presenter: Hanneke Wilmink
Session: Mini oral session: GI tumours, upper
Resources:
Abstract
Slides
Webcast
CN48 - Pilot evaluation of RCC4Nurses to enhance nursing education and practice in survivorship care of people with advanced renal cell carcinoma in Europe
Presenter: Grigorios Kotronoulas
Session: Rehabilitation and survivorship care
Resources:
Abstract
Slides
Webcast
Discussion
Session: Improving outcome in long-term survivors with metastatic NSCLC
Resources:
Webcast
Discussion
Session: YO Forum - Finding your “X-factor”: Skills for professional development
Resources:
Webcast